Skip to main content
Year archive

Bavarian Nordic — 2018 filings

All 115 regulatory filings released by Bavarian Nordic (BAVA) in 2018, sourced directly from the official regulator.

115 Filings
2018 Period
2018 filings (115)
Filing Released Lang
Regulatory Filings 2018
Regulatory Filings
2018-12-23 Danish
Regulatory Filings 2018
Regulatory Filings
2018-12-23 English
Regulatory Filings 2018
Regulatory Filings
2018-12-21 English
De amerikanske sundhedsmyndigheder (FDA) har accepteret og tildelt priority review til Bavarian Nordics registreringsansøgning for MVA-BN® koppevaccine
Regulatory Filings
2018-12-21 Danish
De amerikanske sundhedsmyndigheder (FDA) har accepteret og tildelt priority review til Bavarian Nordics registreringsansøgning for MVA-BN® koppevaccine
Regulatory Filings
2018-12-21 Danish
Bavarian Nordic Announces FDA Acceptance and Priority Review of Biologics License Application for MVA-BN Smallpox Vaccine
Regulatory Filings
2018-12-21 English
Transaction in Own Shares 2018
Transaction in Own Shares
2018-11-13 English
Transaction in Own Shares 2018
Transaction in Own Shares
2018-11-13 English
Transaction in Own Shares 2018
Transaction in Own Shares
2018-11-13 Danish
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
Transaction in Own Shares
2018-11-13 English
Bavarian Nordic - Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program
Regulatory Filings
2018-11-13 English
Regulatory Filings 2018
Regulatory Filings
2018-11-02 English
Regulatory Filings 2018
Regulatory Filings
2018-11-02 English
Legal Proceedings Report 2018
Legal Proceedings Report
2018-11-02 Danish
Bavarian Nordic Announces Initiation of Clinical Trial Evaluating the Combination Therapy of CV301 and Durvalumab in Metastatic Colorectal and Pancreatic Cancers
Regulatory Filings
2018-11-02 English
Bavarian Nordic Announces Initiation of Clinical Trial Evaluating the Combination Therapy of CV301 and Durvalumab in Metastatic Colorectal and Pancreatic Cancers
Regulatory Filings
2018-11-02 English
Regulatory Filings 2018
Regulatory Filings
2018-11-01 English
Legal Proceedings Report 2018
Legal Proceedings Report
2018-11-01 Danish
Legal Proceedings Report 2018
Legal Proceedings Report
2018-11-01 English
Bavarian Nordic offentliggør påbegyndelsen af fase 2 med BN-Brachyury til behandling af chordoma
Regulatory Filings
2018-11-01 Danish
Bavarian Nordic offentliggør påbegyndelsen af fase 2 med BN-Brachyury til behandling af chordoma
Regulatory Filings
2018-11-01 Danish
Bavarian Nordic Announces Initiation of Phase 2 Trial of BN-Brachyury for the Treatment of Chordoma
Regulatory Filings
2018-11-01 English
Legal Proceedings Report 2018
Legal Proceedings Report
2018-09-18 Danish
Regulatory Filings 2018
Regulatory Filings
2018-09-18 English
Legal Proceedings Report 2018
Legal Proceedings Report
2018-09-18 English
Bavarian Nordic offentliggør påbegyndelsen af fase 2 kombinationsforsøg med CV301 og atezolizumab i blærekræft
Regulatory Filings
2018-09-18 Danish
Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Atezolizumab in Bladder Cancer
Regulatory Filings
2018-09-18 English
Earnings Release 2018
Earnings Release H1 2018
2018-08-16 English
Earnings Release 2018
Earnings Release H1 2018
2018-08-16 Danish
Earnings Release 2018
Earnings Release H1 2018
2018-08-16 English
Bavarian Nordic Announces First Half 2018 Results
Report Publication Announcement
2018-08-16 English
Bavarian Nordic offentliggør regnskab for første halvår 2018
Interim / Quarterly Report H1 2018
2018-08-16 English
Capital/Financing Update 2018
Capital/Financing Update
2018-08-09 Danish
Capital/Financing Update 2018
Capital/Financing Update
2018-08-09 English
Capital/Financing Update 2018
Capital/Financing Update
2018-08-09 English
Bavarian Nordic bevilges lån på EUR 30 mio. af den Den Europæiske Investeringsbank
Capital/Financing Update
2018-08-09 Danish
Bavarian Nordic bevilges lån på EUR 30 mio. af den Den Europæiske Investeringsbank
Capital/Financing Update
2018-08-09 Danish
Bavarian Nordic Granted EUR 30 Million Loan from The European Investment Bank
Capital/Financing Update
2018-08-09 English
Regulatory Filings 2018
Regulatory Filings
2018-08-08 English
Regulatory Filings 2018
Regulatory Filings
2018-08-08 English
Regulatory Filings 2018
Regulatory Filings
2018-08-08 Danish
Bavarian Nordic Announces Positive Data from Phase 2 Extension Study of its Universal RSV Vaccine
Regulatory Filings
2018-08-08 English
Bavarian Nordic Announces Positive Data from Phase 2 Extension Study of its Universal RSV Vaccine
Regulatory Filings
2018-08-08 English
Regulatory Filings 2018
Regulatory Filings
2018-07-11 English
Legal Proceedings Report 2018
Legal Proceedings Report
2018-07-11 Danish
Legal Proceedings Report 2018
Legal Proceedings Report
2018-07-11 English
Bavarian Nordic offentliggør påbegyndelsen af fase 2 kombinationsforsøg med CV301 og nivolumab i metastatisk tyktarmskræft
Regulatory Filings
2018-07-11 Danish
Bavarian Nordic offentliggør påbegyndelsen af fase 2 kombinationsforsøg med CV301 og nivolumab i metastatisk tyktarmskræft
Regulatory Filings
2018-07-11 Danish
Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Nivolumab in Metastatic Colorectal Cancer
Regulatory Filings
2018-07-11 English
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
Share Issue/Capital Change
2018-06-07 Danish
Kapitalforhøjelse i Bavarian Nordic A/S som følge af medarbejderes udnyttelse af tegningsoptioner
Regulatory Filings
2018-06-07 Danish
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2018-06-07 English
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise
Share Issue/Capital Change
2018-06-07 English
Regulatory Filings 2018
Regulatory Filings
2018-05-02 English
Regulatory Filings 2018
Regulatory Filings
2018-05-02 English
Regulatory Filings 2018
Regulatory Filings
2018-05-02 Danish
Bavarian Nordic Receives FDA Orphan Drug Designation for BN-Brachyury for the Treatment of Chordoma
Regulatory Filings
2018-05-02 English
Bavarian Nordic Receives FDA Orphan Drug Designation for BN-Brachyury for the Treatment of Chordoma
Regulatory Filings
2018-05-02 English
AGM Information 2018
AGM Information
2018-04-17 English
AGM Information 2018
AGM Information
2018-04-17 English
AGM Information 2018
AGM Information
2018-04-17 Danish
Bavarian Nordic A/S - Report on the Results of the Annual General Meeting, held April 17, 2018
Declaration of Voting Results & Voting Rights Announcements
2018-04-17 English
Bavarian Nordic A/S - Report on the Results of the Annual General Meeting, held April 17, 2018
Declaration of Voting Results & Voting Rights Announcements
2018-04-17 English
AGM Information 2018
AGM Information
2018-03-26 English
AGM Information 2018
AGM Information
2018-03-26 Danish
AGM Information 2018
AGM Information
2018-03-26 English
Bavarian Nordic A/S - Notice Convening Ordinary General Meeting
Proxy Solicitation & Information Statement
2018-03-26 English
Bavarian Nordic A/S - Indkaldelse til ordinær generalforsamling
Proxy Solicitation & Information Statement
2018-03-26 English
Bavarian Nordic A/S - Indkaldelse til ordinær generalforsamling
Proxy Solicitation & Information Statement
2018-03-26 Danish
Regulatory Filings 2018
Regulatory Filings
2018-03-16 English
Regulatory Filings 2018
Regulatory Filings
2018-03-16 Danish
M&A Activity 2018
M&A Activity
2018-03-16 English
Bavarian Nordic indgår kontrakt med det amerikanske forsvar om udvikling af vaccine mod alphavirus
Regulatory Filings
2018-03-16 English
Bavarian Nordic indgår kontrakt med det amerikanske forsvar om udvikling af vaccine mod alphavirus
Regulatory Filings
2018-03-16 Danish
Remuneration Information 2018
Remuneration Information
2018-03-12 English
Remuneration Information 2018
Remuneration Information
2018-03-12 Danish
Bavarian Nordic Awards Restricted Stock Units to Executive Management
Remuneration Information
2018-03-12 English
Bavarian Nordic Awards Restricted Stock Units to Executive Management
Director's Dealing
2018-03-12 English
Report Publication Announcement 2017
Report Publication Announcement FY 2017
2018-03-12 English
Annual Report 2017
Annual Report FY 2017
2018-03-12 English
Report Publication Announcement 2017
Report Publication Announcement FY 2017
2018-03-12 Danish
Bavarian Nordic Announces Annual Report 2017
Report Publication Announcement
2018-03-12 English
Bavarian Nordic Announces Annual Report 2017
Report Publication Announcement
2018-03-12 English
Bavarian Nordic offentliggør årsrapport for 2017
Report Publication Announcement
2018-03-12 English
Regulatory Filings 2018
Regulatory Filings
2018-03-08 English
Regulatory Filings 2018
Regulatory Filings
2018-03-08 Danish
Regulatory Filings 2018
Regulatory Filings
2018-03-08 English
Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite Stable Colorectal Cancer
Regulatory Filings
2018-03-08 English
Bavarian Nordic Announces Phase 2 Trial Investigating Combination of Its Immunotherapy CV301 and Nivolumab in Microsatellite Stable Colorectal Cancer
Regulatory Filings
2018-03-08 English
Regulatory Filings 2018
Regulatory Filings
2018-03-06 English
Earnings Release 2018
Earnings Release FY 2018
2018-03-06 English
Regulatory Filings 2018
Regulatory Filings
2018-03-06 Danish
Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine
Regulatory Filings
2018-03-06 English
Bavarian Nordic Announces Additional Positive Data from a Phase 2 Study of its Universal RSV Vaccine
Regulatory Filings
2018-03-06 English
Regulatory Filings 2018
Regulatory Filings
2018-02-26 English
Regulatory Filings 2018
Regulatory Filings
2018-02-26 English
Regulatory Filings 2018
Regulatory Filings
2018-02-26 Danish
Bavarian Nordic Announces Collaboration to Evaluate CV301 in Combination with durvalumab in Colorectal and Pancreatic Cancers
Regulatory Filings
2018-02-26 English
Bavarian Nordic Announces Collaboration to Evaluate CV301 in Combination with durvalumab in Colorectal and Pancreatic Cancers
Regulatory Filings
2018-02-26 English
Regulatory Filings 2018
Regulatory Filings
2018-02-06 English
Earnings Release 2018
Earnings Release Q1 2018
2018-02-06 English
Earnings Release 2018
Earnings Release Q1 2018
2018-02-06 Danish
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine
Regulatory Filings
2018-02-06 English
Bavarian Nordic Announces Positive Results of Pivotal Phase 3 Study of IMVAMUNE® Smallpox Vaccine
Regulatory Filings
2018-02-06 English
Board/Management Information 2018
Board/Management Information
2018-01-31 English
Board/Management Information 2018
Board/Management Information
2018-01-31 Danish
Board/Management Information 2018
Board/Management Information
2018-01-31 English
Bavarian Nordic Announces the Planned Departure of Chief Financial Officer, Ole Larsen
Board/Management Information
2018-01-31 English
Finansdirektør Ole Larsen stopper i Bavarian Nordic i løbet af 2018
Board/Management Information
2018-01-31 English
Finansdirektør Ole Larsen stopper i Bavarian Nordic i løbet af 2018
Board/Management Information
2018-01-31 Danish
Legal Proceedings Report 2018
Legal Proceedings Report
2018-01-19 English
Regulatory Filings 2018
Regulatory Filings
2018-01-19 Danish
Regulatory Filings 2018
Regulatory Filings
2018-01-19 English
Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis
Regulatory Filings
2018-01-19 English
Bavarian Nordic Announces Initiation of Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis
Regulatory Filings
2018-01-19 English